对比经皮射频消融术和经腹腔镜下肝切除术治疗Ⅰa期原发性肝癌的临床效果

目的对比经皮射频消融术(PRFA)和经腹腔镜下肝切除术治疗Ⅰa期原发性肝癌的临床效果。方法选取罗田县人民医院2015年1月至2017年1月间收治的Ⅰa期原发性肝癌患者114例,采用随机数字法将其分为PRFA组和腔镜组,每组各57例。比较两组患者并发症发生率,治疗前后肝功能水平、生存时间和无瘤生存时间。结果治疗后,PRFA组患者并发症总发生率为7.02%(4/57),腔镜组患者并发症总发生率为24.56%(14/57),差异有统计学意义(χ2=7.00,P<0.05)。治疗前,两组患者血清ALT、AST水平比较,差异均无统计学意义(P>0.05);治疗1个月后,两组患者肝功能水平均显著优于治疗前,且PRFA组患者肝功能水平显著优于腔镜组,差异均有统计学意义(P<0.05);治疗后,PRFA组患者生存时间和无瘤生存时间分别为(34.29±2.88)个月和(27.14±4.16)个月,腔镜组患者生存时间和无瘤生存时间分别为(28.30±4.11)个月和(22.67±3.99)个月,PRFA组患者生存时间和无瘤生存时间均显著优于腔镜组,差异均有统计学意义(P<0.05)。结论针对治疗Ia期原发性肝癌,PRFA与经腹腔镜下肝切除术比较,能够更有利于肝功能恢复,从而更加有效延长患者的生存时间和无瘤生存时间,同时降低并发症发生率,值得在临床推广。

Clinical efficacy comparison of percutaneous radiofrequency ablation and laparoscopic liver resection for the treatment of stage Ia primary liver cancer

Objective To compare the clinical effects of percutaneous radiofrequency ablation and laparoscopic liver resection for primary stage Ia hepatocellular carcinoma.Methods A total of 114 patients with stage Ia primary liver cancer admitted to Luotian County People's Hospital from January 2015 to January 2017 were enrolled.The patients were randomly divided into PRFA group and laparoscopic group,with 57 cases in each group.The PRFA group underwent percutaneous radiofrequency ablation,and the laparoscopic group underwent laparoscopic liver resection.The survival time and tumor-free survival time of the two groups were compared.The liver function of the two groups was compared before and after treatment.The complication rate of the two groups was compared.Results After treatment,the total incidence of complications in the PRFA group was 7.02%(4/57),and the total incidence of complications in the laparoscopic group was 24.56%(14/57).The total incidence of complications in the PRFA group.The difference was statistically significant(P<0.05).There was no significant difference in serum ALT and AST levels between the two groups before treatment(P>0.05).After 1 month of treatment,the two groups were treated.The liver function level of patients was significantly better than that before treatment,and the liver function level of patients in PRFA group was significantly better than that of laparoscopic group,the difference was statistically significant(P<0.05).After treatment,the survival time and tumor-free survival time of the patients in the laparoscopic group were(28.30±4.11)months and(22.67±3.99)months,respectively,and the survival time and absence of the patients in the PRFA group were(34.29±2.88)months and(27.14±4.16)months,respectively.The tumor survival time was significantly better than that of the endoscopy group,and the difference was statistically significant(P<0.05).Conclusion For the treatment of stage Ia primary liver cancer,percutaneous radiofrequency ablation is more conducive to liver function recovery than laparoscopic liver resection,which can effectively prolong the survival time and tumor-free survival time,and reduce the incidence of complications is worthy of clinical promotion.